Radionuclide Therapy Program
About Our Services
Our Society of Nuclear Medicine Designated Clinical Therapy Center of Excellence specializes in providing cutting-edge treatment options for various conditions using advanced radionuclide therapies. Offerings include both Lutathera and Pluvicto, designed to target specific types of cancer cells effectively. These therapies are delivered by our dedicated therapy team comprised of nuclear medicine and radiopharmaceutical experts with more than 75 combined years of experience.
Our Therapies
Lutathera
Lutathera is a targeted therapy used primarily for treating certain types of neuroendocrine tumors. It works by delivering a high dose of radiation directly to the cancer cells while minimizing exposure to surrounding healthy tissues. More information.
Pluvicto
Pluvicto is an innovative treatment option for patients with advanced prostate cancer. This therapy targets prostate-specific membrane antigen (PSMA) positive cells, delivering therapeutic radiation to destroy cancerous cells. More information.
Information for Patients and Physicians
The journey through radionuclide therapy involves several steps:
- Consultation: Initial consultation to determine eligibility and treatment plan.
- Preparation: Pre-treatment instructions and preparation.
- Treatment: Administration of Lutathera or Pluvicto in a controlled medical environment.
- Post-Treatment Care: Follow-up appointments and monitoring to track progress and manage any side effects.
What makes our program unique?
- Critical experience in nuclear medicine and administration of targeted radiopharmaceuticals
- Our team has decades of experience in radiopharmaceutical administration, imaging, and radiation safety to enable highly accurate dose delivery while minimizing exposure to loved ones while undergoing therapy.
- Advanced dosimetry services
- As one of the only places in the country routinely performing dosimetry on our radionuclide therapy patients, we understand the need to determine doses to healthy organs and sites of disease during treatment to optimize care for our patients. Every patient received personalized dosimetry as part of their standard of care so that we can work to create the best possible outcomes and treatment guidance for our patients.
We are dedicated to providing you with all the necessary information and support throughout your treatment journey.
Information for Referring Physicians
We understand the importance of seamless collaboration with referring physicians. We provide comprehensive support and detailed information about our therapies, including patient eligibility, treatment protocols, and expected outcomes. Our goal is to ensure that your patients receive the best possible care tailored to their needs. Please click on the link below for more information related to patient referrals and staff contacts.
Contact Us
For more information about our services, or to schedule a consultation, please contact us at:
- Fax: 865-305-8694
- Email: mitrp@utmck.edu
Thank you for choosing the MITRP Radionuclide Therapy service. We are committed to providing you with the highest level of care coupled with the most advanced treatment options available.
